Overview
Pamela Mccall practices practicing medicine in Glasgow, United Kingdom.
Her clinical expertise encompasses Prostate Cancer, Triple-Negative Breast Cancer, and Pancreaticoduodenectomy.
She is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Pamela Mccall
Is Pamela Mccall a top-rated expert for Pancreaticoduodenectomy?
MediFind is an objective health platform that identifies experts based on real-world data. Pamela Mccall is classified as an Experienced expert for Pancreaticoduodenectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Pamela Mccall participate in research or clinical trials?
Yes. Pamela Mccall has published 8 articles and abstracts on conditions like Pancreaticoduodenectomy. You can view a list of Pamela Mccall's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- PancreaticoduodenectomyMs. Mccall isExperienced. Learn about Pancreaticoduodenectomy.
- Prostate CancerMs. Mccall isExperienced. Learn about Prostate Cancer.
- Triple-Negative Breast CancerMs. Mccall isExperienced. Learn about Triple-Negative Breast Cancer.